Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
Suptavumab for the Prevention of Medically Attended Respiratory Syncytial Virus Infection in Preterm Infants.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: February 26, 2020
CHF5074 Reduces Biomarkers of Neuroinflammation in Patients with Mild Cognitive Impairment: A 12-Week, Double-Blind, Placebo-Controlled Study.
Journal: Current Alzheimer research
Published: December 29, 2012
Long-term efficacy and safety of aerosolized tobramycin 300 mg/4 ml in cystic fibrosis.
Journal: Pediatric pulmonology
Published: December 21, 2012
Pharmacokinetic and tolerability profiles of tobramycin nebuliser solution 300 mg/4 ml administered by PARI eFlow(®) rapid and PARI LC Plus(®) nebulisers in cystic fibrosis patients.
Journal: Pulmonary pharmacology & therapeutics
Published: October 08, 2012
CHF5074 reduces biomarkers of neuroinflammation in patients with mild cognitive impairment: a 12-week, double-blind, placebo-controlled study.
Journal: Current Alzheimer research
Published: April 17, 2012
Showing 1-6 of 6
Last Updated: 09/26/2026